Nureca Limited Reports Strong Q2 FY26 Performance with 21% YoY Revenue Growth

2 min read     Updated on 16 Oct 2025, 05:54 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
Overview

Nureca Limited, a home healthcare and wellness products company, has announced its Q2 FY2026 results. Revenue increased by 21% year-over-year to ₹37.70 crore, while net profit rose to ₹3.60 crore from a loss of ₹0.50 crore in Q2 FY2025. Operating profit surged by 237.50% to ₹3.30 crore. The company attributes its success to cost optimization, growth in quick commerce sales channels, and a digital-first approach with over 93% of revenue from online sales. Nureca maintains a debt-free, asset-light business model.

22163054

*this image is generated using AI for illustrative purposes only.

Nureca Limited , a prominent player in the home healthcare and wellness products sector, has released its financial results for the second quarter and half-year ended September 30, 2025, revealing a strong performance with significant growth in revenue and profitability.

Financial Performance

The company's unaudited consolidated financial results for Q2 FY2026 show:

Particulars (₹ in crore) Q2 FY2026 Q2 FY2025 YoY Change H1 FY2026 H1 FY2025 YoY Change
Revenue from Operations 37.70 31.20 21.00% 71.90 51.50 40.00%
Net Profit 3.60 (0.50) N/A N/A N/A N/A
Operating Profit 3.30 (2.40) 237.50% N/A N/A N/A

Nureca Limited demonstrated robust growth in its quarterly performance. The company's revenue increased by 21% year-over-year, reaching ₹37.70 crore in Q2 FY2026 compared to ₹31.20 crore in Q2 FY2025. For the first half of FY2026, revenue showed an impressive 40% growth, reaching ₹71.90 crore compared to ₹51.50 crore in H1 FY2025.

The company's profitability saw a significant turnaround. Operating profits surged by 237.50% year-over-year to ₹3.30 crore, compared to a loss of ₹2.40 crore in the same quarter last year. Net profit after tax increased substantially to ₹3.60 crore from a loss of ₹0.50 crore in Q2 FY2025.

Key Factors Contributing to Performance

Nureca attributed its strong performance to several factors:

  1. Focused Cost Optimization: The company's efforts in streamlining operations and reducing costs have contributed to the improved profitability.

  2. Growth in Quick Commerce Sales Channels: The expansion and success in quick commerce channels have driven revenue growth.

  3. Digital-First Approach: Nureca operates as a digital-first healthcare company, with over 93% of its revenue generated through online sales.

  4. Asset-Light Business Model: The company maintains a debt-free, asset-light business model, which contributes to its financial flexibility and efficiency.

Business Model and Strategy

Nureca's business model is characterized by its strong focus on digital channels and asset-light operations:

  1. Digital-First Strategy: With more than 93% of revenue coming from online sales, Nureca has successfully leveraged e-commerce platforms to reach its customers.

  2. Debt-Free Operations: The company's debt-free status provides financial stability and reduces interest expenses.

  3. Asset-Light Model: This approach allows for greater flexibility and potentially higher returns on invested capital.

Market Outlook

The home healthcare and wellness products sector continues to show strong growth potential, driven by increasing health consciousness and the convenience of home-based care solutions. Nureca's digital-first approach and focus on quick commerce channels position it well to capitalize on these trends.

Conclusion

Nureca Limited's Q2 FY2026 results demonstrate the company's ability to drive significant revenue growth and achieve profitability in a competitive market. The substantial improvements in both top-line and bottom-line figures underscore the effectiveness of the company's strategies, particularly its digital-first approach and focus on cost optimization.

As Nureca continues to expand its presence in the quick commerce space and maintain its asset-light, debt-free model, the company's ability to sustain this growth trajectory and further improve its market position in the home healthcare and wellness products industry will be closely watched by investors and market observers.

Historical Stock Returns for Nureca

1 Day5 Days1 Month6 Months1 Year5 Years
+2.02%+5.36%-4.93%+2.57%-19.30%-62.46%

Nureca Limited CFO Naresh Gupta to Step Down in January 2026

1 min read     Updated on 11 Oct 2025, 06:50 PM
scanx
Reviewed by
Ashish ThakurScanX News Team
Overview

Naresh Gupta, Chief Financial Officer of Nureca Limited, has submitted his resignation. The resignation will be effective from January 9, 2026, at the close of business hours. Nureca Limited has informed the stock exchanges about this development in compliance with SEBI regulations. The company has a three-month transition period to ensure smooth handover and potentially identify a successor. This announcement comes ahead of Nureca's scheduled board meeting on October 16, 2025, to consider Q2 and half-year financial results.

21734409

*this image is generated using AI for illustrative purposes only.

Nureca Limited , a prominent player in the healthcare and wellness sector, has announced a significant change in its leadership team. Chief Financial Officer (CFO) Naresh Gupta has tendered his resignation, marking the end of his tenure with the company.

Key Details of the Resignation

Aspect Information
Resigning Executive Naresh Gupta
Position Chief Financial Officer (CFO)
Resignation Date October 11, 2025
Effective Date January 9, 2026 (close of business hours)
Reason As per resignation letter (specifics not disclosed)

Corporate Governance and Disclosure

In adherence to regulatory requirements, Nureca Limited has promptly informed the stock exchanges about this development. The company has filed the necessary intimation with both the BSE Limited and the National Stock Exchange of India Limited, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transition Period

The extended notice period of approximately three months provides Nureca Limited with ample time to ensure a smooth transition. This period allows the company to potentially identify and onboard a successor, ensuring continuity in financial leadership.

Additional Insights

  • Nureca Limited has confirmed that apart from the reasons mentioned in Gupta's resignation letter, there are no other material reasons for his departure.
  • The company's proactive disclosure aligns with best practices in corporate governance, maintaining transparency with its shareholders and the market at large.
  • This announcement comes just days before Nureca's scheduled board meeting on October 16, 2025, where the company plans to consider and approve its unaudited financial results for the second quarter and half-year ended September 30, 2025.

As Nureca Limited navigates this transition in its financial leadership, stakeholders will likely be keen to observe any potential impacts on the company's financial strategy and performance in the coming quarters. The market will also be watching closely for announcements regarding Gupta's successor in the CFO role.

Historical Stock Returns for Nureca

1 Day5 Days1 Month6 Months1 Year5 Years
+2.02%+5.36%-4.93%+2.57%-19.30%-62.46%
More News on Nureca
Explore Other Articles
242.43
+4.81
(+2.02%)